|
⚲
|
| Keyboard |
| Sessa Capital GP LLC | |
|---|---|
| Firm | Sessa Capital IM LP |
| Address | 888 Seventh Avenue 30th Floor New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Sessa Capital IM LP | |||||
| Sessa Capital Special Opportunity Fund III LP | 021-448036 | Director | 97.4 M | 1.8 M | |
| Sessa Capital Special Opportunity Fund II LP | 021-330670 | Director | 867.3 M | 1,907.2 M | |
| Sessa Capital Special Opportunity Fund I LP | 021-257343 | Director | 5.7 M | ||
| Sessa Capital Master LP | 021-186969 | Director | 554.2 M | 5,615.2 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2025-09-29 | Option exercise | 1,740,000 | $1.75 | 3,045,000 |
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-09-29 | Option exercise | 17,400 | ||
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-07-22 | Grant | 228,500 | ||
|
SAB Biotherapeutics Inc SABS
Warrants (right to buy) · derivative
|
2025-07-22 | Grant | 228,500 | ||
|
SAB Biotherapeutics Inc SABS
Warrants (right to buy) · derivative
|
2025-07-22 | Grant | 114,250 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2024-03-06 | Sell | 10,000,000 | $9.00 | 90,000,000 |
|
SAB Biotherapeutics Inc SABS
Series A-2 Convertible Preferred Stock · derivative
|
2023-11-24 | Option exercise | 28,380 | $1,000.00 | 28,380,000 |
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-11-24 | Option exercise | 31,269 | $1,000.00 | 31,269,000 |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2023-11-24 | Option exercise | 4,584,571 | ||
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-11-13 | Grant | 13,269 | $1,000.00 | 13,269,000 |
|
SAB Biotherapeutics Inc SABS
Tranche A Warrants · derivative
|
2023-11-13 | Option exercise | 13,269 | ||
|
SAB Biotherapeutics Inc SABS
Tranche B Warrants · derivative
|
2023-11-10 | Grant | 8,846 | ||
|
SAB Biotherapeutics Inc SABS
Tranche C Warrants · derivative
|
2023-11-10 | Grant | 22,115 | ||
|
SAB Biotherapeutics Inc SABS
Tranche A Warrants · derivative
|
2023-11-10 | Grant | 13,269 | ||
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-10-23 | Grant | 16,269 | $1,000.00 | 16,269,000 |
|
SAB Biotherapeutics Inc SABS
Tranche A Warrants · derivative
|
2023-10-23 | Option exercise | 16,269 | ||
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-13 | Option exercise | 1,731,896 | ||
|
Garrett Motion Inc GTX
Series A Preferred Stock · derivative
|
2023-06-06 | Option exercise | 16,592,384 | $0.00 | |
|
Garrett Motion Inc GTX
Common Stock
|
2023-06-06 | Option exercise | 16,592,384 | ||
|
Provention Bio Inc PRVB
Common Stock
|
2023-04-27 | Tender | 15,567,497 | ||
| showing 20 of 30 most recent transactions | |||||